个性化文献订阅>期刊> Bioorganic & Medicinal Chemistry Letters
 

Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: Extending towards the beta-exosite

  作者 Smith, GR; Caglic, D; Capek, P; Zhang, Y; Godbole, S; Reitz, AB; Dickerson, TJ  
  选自 期刊  Bioorganic & Medicinal Chemistry Letters;  卷期  2012年22-11;  页码  3754-3757  
  关联知识点  
 

[摘要]Botulinum neurotoxins (BoNTs) are the most toxic proteins known to man, exposure to which results in flaccid paralysis. Given their extreme potency, these proteins have become studied as possible weapons of bioterrorism; however, effective treatments that function after intoxication have not progressed to the clinic. Here, we have reexamined one of the most effective inhibitors, 2,4-dichlorocinnamyl hydroxamate, in the context of the known plasticity of the BoNT/A light chain metalloprotease. Our studies have shown that modifications of this compound are tolerated and result in improved inhibitors, with the best compound having an IC50 of 0.23 mu M. Given the inconsistency of structure-activity relationship trends observed across similar compounds, this data argues for caution in extrapolating across structural series (C) 2012 Elsevier Ltd. All rights reserved.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内